COVID-19 Updates
-
Phoenix PharmaLabs Announces New Investment Offering with Netcapital
Phoenix PharmaLabs (Phoenix), a Utah company developing potent, non-addictive treatments for pain and opioid and cocaine addictions, announced…
-
Medsential Offering an FDA EUA Approved COVID Point of Care Antibody Rapid Test
Medsential has announced that it is now offering COVID-19 IgM/IgG rapid antibody tests to point of care providers…
-
ELITech’s COVID, Flu, RSV Multiplex Test Receives CE Mark
ELITech Group recently announced its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been released. The…
-
Event: Utah’s Coronavirus Pandemic Response
On January 7, join the three-hour event featuring topics such as company COVID responses, the pandemic’s impact on…
-
Congress Nears Deal on COVID-19 Stimulus Package
Leaders of both parties inched closer on Thursday to agreement on a COVID-19 stimulus package. The package would…
-
Utah Readies to Receive 154,000 COVID-19 Vaccines
Governor Herbert yesterday announced that teachers would move up to the front of the line for the COVID-19…
-
Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test
Co-Diagnostics announced November 25 that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing…
-
Braveheart Brings Healthcare to India’s Last Mile Community
These days we can all use uplifting news, so please check out this short story about how BraveHeart…
-
Utah COVID-19 Small Business Quarantined Employee Grants
Utah continues to support the business community during the COVID-19 pandemic with its COVID-19 Small Business Quarantined Employee…
-
Who’s First In Line for the COVID Vaccine? CDC’s Immunization Advisory Committee Makes Recommendations
With the first shipments of the Pfizer/BioNTech vaccine scheduled to arrive in a matter of weeks and Moderna…
-
Most Favored Nation Rule Poses Patient Access Issues, Faces Legal Challenges
As reported in last week’s BioUtah News and Events, HHS on Nov. 20 released an interim final rule…
-
Milken Institute Ranks Utah Sixth in Nation for Innovation Capacity
The Milken Institute 2020 State Technology and Science Index ranks Utah #6 in the nation for its knowledge…
-
FDA Posts Serology Templates for Test Developers
The FDA on Nov. 24 posted two templates with recommendations on what to include in EUA requests for…
-
COVID-19 Vaccination Briefing From the State of Utah.
View the briefing below: COVID-19 Vaccination Update_11-17-2020
-
Utah Life Sciences Leaders Honored At 2020 Virtual Life Sciences Summit
On the last day of the Summit, BioUtah announced its 2020 Utah Life Sciences award winners, which were presented during…
-
Quansys Biosciences Receives EUA for COVID-19 Antibody Test, Provides Exceptional Clinical Performance
Quansys Biosciences has received emergency use authorization (EUA) from the FDA for its COVID-19 antibody test. The test…
-
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
-
BioHive Launched at Utah Life Sciences Summit – Join the Campaign
The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the…
-
Transit Scientifc’s New Angioplasty System Dilates Calcified & Fibrotic Vessels
Transit Scientific’s new FDA cleared XO Score system was successfully used to dilate multiple challenging fibrotic and calcific…
-
Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal
Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement…
-
Sanofi Commits $1M to Support Parkinson’s Disease Genetic Research
Sanofi and the Parkinson’s Foundation announced on Wednesday a new research collaboration to advance the availability of genetic…
-
SBA Extends PPP Loan Deferral, New Streamlined Forgiveness for Loans of $50,000 or Less
On October 7, the SBA released updated FAQs (question #52) to clarify that lenders must recognize the extended…
-
IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections
Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse…
-
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the…
-
Governor Herbert Announces New COVID-19 Transmission Index
On Wednesday, Governor Herbert announced the state’s new response plan to COVID-19, effective October 15. This updated plan…
-
Pediatric Rare Disease Voucher Program Extended
Congress recently provided a short-term extension until December 11 of the Rare Pediatric Disease Priority Review Voucher program.…
-
SINTX Technologies Develops New Mask Fabric with Silicon Nitride
On Tuesday, SINTX Technologies (SINTX) announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory…
-
Mountain Pacific Venture Fund Invests in SLC Laparoscopic Device Company Xenocor
Utah-based Mountain Pacific Venture Fund (MPVF) announced on Monday an investment in Xenocor, a Salt Lake City-based medical…
-
Johnson & Johnson Signs Communiqué on Expanded Global Access for COVID-19
Johnson & Johnson recently announced that it’s joined 15 other companies in signing a Communiquie on Expanded Global…
-
U OF U Establishes Partners For Innovation, Ventures, Outreach & Technology
U of U President Ruth V. Watkins announced on September 30 that the U has formed the Partners…
-
Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives
Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized…
-
Foldax Named Finalist in the Fierce Innovation Awards
Salt Lake City-based Foldax® was a finalist in the recent Fierce Innovation Awards – Life Sciences Edition 2020,…
-
Alucent Biomedical Announces $35 Million Series B Financing
Alucent Biomedical, a Salt Lake-City based company and BioUtah member, founded to transform the way vascular disease is…
-
IONIQ Sciences’ ProLung Test Accepted for Submission to China’s National Medical Products Administration
IONIQ Sciences, based in Salt Lake City, and a BioUtah member, announced September 20 that its IONIQ ProLung…
-
J&J Enters Phase 3 Trial for COVID-19 Vaccine
BioUtah member Johnson & Johnson (J&J) announced that they’ve started the global phase 3 trial of Janssen’s single-dose…
-
SDP Oncology Announces New Data from Phase 1 Solid Tumor Study
Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) and BioUtah member recently announced new data from the ongoing Phase…
-
President Trump Signs Executive Order on Healthcare, Pre-existing Conditions
During a campaign event yesterday in Charlotte, North Carolina, President Trump signed an executive order on a range…
-
RenalytixAI Receives California Commercial Lab Certification
RenalytixAI – a BioUtah member – announced on Tuesday that it has received a California Clinical Laboratory License from…
-
Trump Administration Releases COVID-19 Vaccine Distribution Strategy
The Administration on Wednesday released a detailed plan for the distribution of free COVID-19 vaccines beginning next year.…
-
Fulgent Genetics Lands Utah COVID-19 Testing Contract
TestUtah has some new twists. Following the expiration of certain state contracts September 1, the Utah Department of…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
